Apuli Maricel Insider Trading Activity
Apuli Maricel has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
BBIO is the most-traded position with 5 trades. The largest single transaction was a sale of BBIO for $149K on Dec 8, 2025.
Performance Scorecard
Forward stock performance after each transaction by Apuli Maricel. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.0% | 40% | 5 |
| 90 days | — | -3.7% | 50% | 4 |
| 120 days | — | -13.6% | 50% | 4 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBBIO · BridgeBio Pharma, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Apuli Maricel bought and sold BBIO.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Apr 30, 2026 | BBIO | Sell | 2,000 | $71.58 | $143K | −1.5% | Chief Accounting Officer | |
Feb 26, 2026 | BBIO | Sell | 2,000 | $66.00 | $132K | −1.6% | Chief Accounting Officer | |
Feb 17, 2026 | BBIO | Sell | 510 | $74.31 | $38K | −0.4% | Chief Accounting Officer | |
Dec 8, 2025 | BBIO | Sell | 2,000 | $74.26 | $149K | −1.5% | Chief Accounting Officer | |
Aug 7, 2025 | BBIO | Sell | 1,000 | $45.44 | $45K | −0.7% | Chief Accounting Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 5 | $507K |
Other insiders at BridgeBio Pharma, Inc.
8 other tracked filers at BBIO.